The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds which act as ligands for the .alpha.7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

 
Web www.patentalert.com

< Pharmaceutical composition and method for treating disorders of the central nervous system

< Pyrrolopyridine derivative and use thereof

> Compounds for the treatment of CNS and amyloid associated diseases

> Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

~ 00278